DT
Therapeutic Areas
4HF Biotec Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SELECTHERA | Prostate and Lung Carcinomas | Preclinical |
Leadership Team at 4HF Biotec
PD
Prof. Dr. H. H. Fiebig, MD, PhD
Chief Executive Officer (CEO) and Founder
DV
Dr. Vincent Vuaroqueaux, PhD
Chief Scientific Officer (CSO)
AH
Anja Honeker, Dipl. Economist
Administration, Finance
DA
Dr. Anne-Lise Peille, PhD
Senior Scientist Target ID and Development
MS
Mirko Schmitz, MSc
In Silico Chemistry, Molecular Docking/Modelling
DP
Dr. Pablo Anton Garcia, PhD
Computational Biology, Cancer OMICS & Biomarker Discovery
FS
Florian Schmidt
App Developer, IT Specialist